| Business Summary | | Physiometrix,
Inc.
designs,
develops,
manufactures
and
markets
non-invasive,
advanced
medical
products,
incorporating
proprietary
materials,
electronics
technology
and
software
for
use
in
neurological
monitoring
applications
during
surgical
and
diagnostic
procedures.
The
Company
sells
its
products
for
use
in
hospitals,
clinics
and
physicians'
offices
domestically
and
internationally.
Its
principal
product
focus
is
its
Patient
State
Analyzer
(PSA4000),
a
system
for
monitoring
brain
activity
during
anesthesia.
The
PSA4000
provides
a
simplified,
user-friendly
analysis
of
patient
brain
activity
during
surgical
procedures
involving
general
anesthesia.
The
Company's
initial
products
are
its
e-Net
headpiece
and
disposable
HydroDot
biosensors,
which
are
based
upon
its
proprietary
HydroGel
technology,
and
its
custom
electronics.
These
products
are
packaged
as
the
HydroDot
NeuroMonitoring
System. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | PHYX
designs,
develops,
manufactures
and
markets
noninvasive
medical
products
incorporating
proprietary
materials,
electronics
technology
and
software
for
use
in
neurological
monitoring
applications
during
surgical
and
diagnostic
procedures.
For
the
six
months
ended
6/30/01,
revenues
totalled
$2.6
million,
up
from
$179
thousand.
Net
loss
rose
91%
to
$4.1
million.
Results
reflect
a
distribution
agreement
with
Baxter,
offset
by
increased
product
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Thomas Baruch, 62 Chairman
of Directors | -- | John Williams, 53 Pres,
CEO, Director | $270K | Daniel Muehl, 38 CFO,
VP of Fin. and Admin. | 209K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|